Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S.
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S.
Gastroenterologist
M.B.B.S., F.C.P.S.
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP II (London)
Diabetologist
M.B.B.S, P.G Diabetes, M.Sc Diabetes
Infectious Disease Specialist
M.B.B.S., F.C.P.S., F.C.P.S.
Gastroenterologist
MBBS,, MRCP (Medicine), EBGH (Gastroenterology & Hepatology), MRCPI(Medicine)
Gastroenterologist
MBBS,, MRCP (Medicine), EBGH (Gastroenterology & Hepatology), MRCPI(Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures